121 related articles for article (PubMed ID: 23455005)
1. Siah: a promising anticancer target.
Wong CS; Möller A
Cancer Res; 2013 Apr; 73(8):2400-6. PubMed ID: 23455005
[TBL] [Abstract][Full Text] [Related]
2. Siah proteins: novel drug targets in the Ras and hypoxia pathways.
House CM; Möller A; Bowtell DD
Cancer Res; 2009 Dec; 69(23):8835-8. PubMed ID: 19920190
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
[TBL] [Abstract][Full Text] [Related]
4. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
5. [Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma].
Brauckhoff A; Ehemann V; Schirmacher P; Breuhahn K
Verh Dtsch Ges Pathol; 2007; 91():269-77. PubMed ID: 18314624
[TBL] [Abstract][Full Text] [Related]
6. Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells.
Malz M; Aulmann A; Samarin J; Bissinger M; Longerich T; Schmitt S; Schirmacher P; Breuhahn K
Int J Cancer; 2012 Nov; 131(9):2016-26. PubMed ID: 22323152
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ubiquitin ligase Siah-1A by disabled-1.
Park TJ; Hamanaka H; Ohshima T; Watanabe N; Mikoshiba K; Nukina N
Biochem Biophys Res Commun; 2003 Mar; 302(4):671-8. PubMed ID: 12646221
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
[TBL] [Abstract][Full Text] [Related]
10. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
[TBL] [Abstract][Full Text] [Related]
11. Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.
Bruzzoni-Giovanelli H; Fernandez P; Veiga L; Podgorniak MP; Powell DJ; Candeias MM; Mourah S; Calvo F; Marín M
J Exp Clin Cancer Res; 2010 Feb; 29(1):10. PubMed ID: 20144232
[TBL] [Abstract][Full Text] [Related]
12. SIAH-1 interacts with mammalian polyhomeotic homologues HPH2 and affects its stability via the ubiquitin-proteasome pathway.
Wu H; Lin Y; Shi Y; Qian W; Tian Z; Yu Y; Huo K
Biochem Biophys Res Commun; 2010 Jul; 397(3):391-6. PubMed ID: 20471960
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of covalent Siah inhibitors.
Stebbins JL; Santelli E; Feng Y; De SK; Purves A; Motamedchaboki K; Wu B; Ronai ZA; Liddington RC; Pellecchia M
Chem Biol; 2013 Aug; 20(8):973-82. PubMed ID: 23891150
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells.
Jang KL; Shackelford J; Seo SY; Pagano JS
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18431-6. PubMed ID: 16344472
[TBL] [Abstract][Full Text] [Related]
15. Central role of SIAH inhibition in DCC-dependent cardioprotection provoked by netrin-1/NO.
Li Q; Wang P; Ye K; Cai H
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):899-904. PubMed ID: 25561546
[TBL] [Abstract][Full Text] [Related]
16. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.
Lipkowitz S; Weissman AM
Nat Rev Cancer; 2011 Aug; 11(9):629-43. PubMed ID: 21863050
[TBL] [Abstract][Full Text] [Related]
17. An N-terminal SIAH-interacting motif regulates the stability of the ubiquitin specific protease (USP)-19.
Velasco K; Zhao B; Callegari S; Altun M; Liu H; Hassink G; Masucci MG; Lindsten K
Biochem Biophys Res Commun; 2013 Apr; 433(4):390-5. PubMed ID: 23500468
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic translation elongation factor 1 delta inhibits the ubiquitin ligase activity of SIAH-1.
Wu H; Shi Y; Lin Y; Qian W; Yu Y; Huo K
Mol Cell Biochem; 2011 Nov; 357(1-2):209-15. PubMed ID: 21633900
[TBL] [Abstract][Full Text] [Related]
19. Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions.
Fukuba H; Takahashi T; Jin HG; Kohriyama T; Matsumoto M
Neurosci Lett; 2008 Mar; 433(3):209-14. PubMed ID: 18280659
[TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
